# Why hospitals get paid: fee-for-service versus value-based care
A patient with pneumonia gets admitted, treated well, and discharged in four days. Under one payment contract, the hospital books a healthy profit. Under a different contract for the exact same patient with the exact same great outcome, the hospital loses money. The clinical care did not change. The financial risk did.
This lesson is about that gap: who bears the risk, and why it decides whether a hospital thrives or drowns.
Hospitals run on two very different logics for getting paid.
Fee-for-service (FFS): the hospital gets paid for each unit of care it delivers. More tests, more procedures, more days in a bed usually means more revenue. Volume drives income.
Value-based care (VBC): the hospital gets paid based on outcomes, cost efficiency, or a fixed budget for a defined episode or population. Doing more does not automatically mean earning more. In many arrangements, doing more can cost the hospital money.
The shift from FFS to VBC is the single biggest financial storyline in the sector, driven largely by Medicare, the federal insurance program for people 65 and older, which is the largest single payer in the United States.
Most inpatient stays are paid using a DRG (Diagnosis-Related Group). Instead of paying for every bandage and blood draw, Medicare groups the stay into a category (for example, "pneumonia with complications") and pays a roughly fixed amount for that category.
So the DRG rewards efficiency within a single stay and more stays overall.
Let's use round, illustrative numbers (not real rates).
Discharge the patient in four days at a cost below the fixed payment, and the hospital wins. If that same patient bounces back a week later with a new infection, that readmission often generates *another* DRG payment. Under pure FFS logic, the readmission is more revenue.
That is exactly the behavior payers wanted to stop.
Value-based contracts flip the incentive. Two of the most important models:
Bundled payments: one fixed price covers an entire episode of care across a time window, often including the hospital stay *and* what happens afterward (rehab, follow-up, readmissions) for something like 30, 60, or 90 days.
Shared-savings ACOs: an ACO (Accountable Care Organization) is a group of doctors and hospitals that takes collective responsibility for a defined population of patients. Medicare sets a spending benchmark. If the ACO keeps total costs below the benchmark while meeting quality targets, it shares in the savings. In the tougher versions, if it goes over, it shares in the losses. That is called downside risk.
You can read Medicare's own overview of the largest such program, the Medicare Shared Savings Program, on the CMS website.
Take the same pneumonia patient. Now the payment is a 90-day bundle.
But now the readmission is the hospital's problem, not a new payday.
Same clinical event. Under DRG, the readmission was extra revenue. Under the bundle, it is a loss. That is the entire point: the bundle makes the hospital financially responsible for what happens *after* discharge, so it invests in prevention (medication counseling, follow-up calls, home health) to keep the patient out.
The DRG puts most risk on the payer. If the patient comes back, the payer pays again.
The bundle and the downside-risk ACO push risk onto the provider. The hospital now behaves like a mini insurance company for that episode or population. If patients stay healthy and out of the building, the hospital keeps more money. If they get sicker, the hospital eats the cost.
This is why value-based care can either enrich or bankrupt a health system:
🎬 [VIDEO: "How Value-Based Care Works" — youtube.com — a short, plain-language explainer of the shift from paying for volume to paying for outcomes]
The through-line: payment models price different things.
FFS prices *activity*. VBC prices *results and total cost*. So a great four-day recovery is:
The clinical excellence is necessary in both worlds. But under VBC, excellence has to extend past the hospital walls into the weeks and months after discharge, a period FFS hospitals historically ignored because they did not get paid to care about it.
Most hospitals in 2026 live in both worlds at once. A large share of their revenue is still FFS, while a growing share sits in value-based contracts. This creates a genuine conflict:
An executive team cannot fully optimize for both. This "one foot on each side" reality is why transformation is slow and why many systems move cautiously, taking on upside-only contracts (share savings, no downside penalty) before accepting full risk.
Knowledge check
1. The lesson opens with an identical patient and identical great outcome producing profit under one contract and a loss under another. What core concept does this illustrate?
2. What fundamentally distinguishes value-based care (VBC) from fee-for-service (FFS)?
3. Why does the DRG payment model, despite being a bundled price for a single admission, still lean toward volume incentives?
4. Select ALL correct answers about how the DRG payment model shapes hospital incentives.
Select all the correct answers.
5. Select ALL correct answers describing why the shift from FFS to VBC is described as a major financial storyline for hospitals.
Select all the correct answers.
When you look at a contract or a strategy deck, ask four questions:
1. What is the unit of payment? A procedure, an admission (DRG), a 90-day episode (bundle), or a whole population (ACO)?
2. Who keeps the savings? If the hospital treats a patient for less than the payment, does it pocket the difference or return it?
3. Is there downside risk? Can the hospital *lose* money if costs run high, or is the worst case simply earning zero bonus?
4. How wide is the time window? The longer the window, the more the hospital owns post-discharge outcomes like readmissions.
Those four answers tell you almost everything about how a hospital will behave. Payment models are not accounting details. They are behavior engines.
Every figure in this lesson is illustrative. Real DRG rates vary by region, hospital type, patient severity, and annual Medicare updates. Real bundle and ACO benchmarks are set through complex formulas and negotiations. Do not treat these examples as market rates. Treat them as the *shape* of the incentives, which is what actually drives strategy.